- Home
- AACG vs INMB Comparison
AACG vs INMB Comparison
Compare AACG & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AACG | INMB |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.5M | 39.6M |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AACG | INMB |
|---|---|---|
| Price | $0.95 | $1.99 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 6.4K | ★ 1.1M |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.74 | $1.09 |
| 52 Week High | $2.58 | $3.24 |
Technical Indicators
Market Signals| Indicator | AACG | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 64.89 |
| Support Level | $0.87 | $1.21 |
| Resistance Level | $1.08 | $2.30 |
| Average True Range (ATR) | 0.05 | 0.17 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 23.53 | 72.00 |
Price Performance
Historical ComparisonAbout AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.